McGuireWoods Brussels Team Advises Pluriomics in Merger to Form New Biotech Company
A team of lawyers from McGuireWoods’ Brussels office helped Belgium-based Pluriomics establish Ncardia — a new privately held biotech group with operations in Europe and the United States — through a complex cross-border merger with its German-based competitor Axiogenesis.
Ncardia secured an additional €4.25 million investment from existing investors Vesalius Biocapital, SFPI/FPIM and Sambrinvest as a direct result of the merger, announced Sept. 18.